Parker Waichman LLP

Tobacco Co. Funded Lung Cancer Study Elicits Mea Culpa from New England Journal of Medicine

After embarrassing disclosures of financial links between the authors of a lung-cancer study and two large companies—General Electric and Vector Group, Ltd.—the New England Journal of Medicine published a correction, a clarification, and an editorial that called for the transparent disclosure of funding sources.  The lung-cancer study, which the journal published in 2006, has been […]

After embarrassing disclosures of financial links between the authors of a lung-cancer study and two large companies—General Electric and Vector Group, Ltd.—the New England Journal of Medicine published a correction, a clarification, and an editorial that called for the transparent disclosure of funding sources.  The lung-cancer study, which the journal published in 2006, has been controversial and suggested an annual screening with a CT scan could reduce the death rate from lung cancer, the top cancer killer.  Critics said the study revealed that screening could detect cancers earlier—not that screening could avert deaths.  GE is a big CT scanner maker and Vector is part of the Liggett Group, a large <"https://www.yourlawyer.com/topics/overview/Florida_cigarette_tobacco">cigarette maker.

In the correction, the New England Journal acknowledges the study’s lead authors, Claudia Henschke and David Yankelevitz of Cornell University’s Weill Medical College in New York City, received royalties from GE for pending patents on ways to manipulate and interpret CT scans and other medical images.

In late 2006, Henschke released a study revealing that the vast majority of lung cancer deaths could be prevented through widespread use of CT scans.  The study was published in The New England Journal of Medicine and indicated—in small print at the end of the piece—the work was financed, in part, by the Foundation for Lung Cancer:  Early Detection, Prevention & Treatment.  A tax record review revealed the foundation was almost entirely underwritten by $3.6 million in grants from the Vector Group, of Liggett Select, Eve, Grand Prix, Quest, and Pyramid cigarette brands.  From 2000 to 2003, the foundation received four grants from Vector.

A spokesman for the doctors said they told the New England Journal that Cornell licensed the pending patents to GE before the study was printed, but not that they were personally receiving royalty shares.  Jeffrey Drazen, the New England Journal’s chief editor, said the publication learned of the royalties recently and that the journal will ask future researchers to provide details on funding sources. “It had not been a practice at the time to ask people about the pedigree of their sources,” Dr. Drazen said. “This has been a learning process for us.”  The New England Journal also published a clarification from Henschke, acknowledging the study was funded, in part, by tobacco giant Vector.

In 2006, Vector announced it was funding Henschke’s work, but didn’t mention the connection to the tobacco industry; it claimed “no control or influence over the research.”  The New England Journal called for clearer disclosure of funding sources saying readers “cannot fully appreciate a study’s meaning without acknowledging the subtle biases in design and interpretation that may arise when a sponsor stands to gain from the report.  We and our readers were surprised to learn that the source of the funding of the charitable foundation was, in fact, a large corporation that could have an interest in the study results.”  The journal also questioned the “advisability of research entities accepting funding from tobacco companies” except through foundations set up following litigation between states and tobacco companies.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I have been working with Tina for about a year and a half. She is a wonderful person and a true professional. I can't thank her enough.
Mike Antidormi
3 years ago
5 Star Reviews 150
Keith Meyers
6 years ago
5 Star Reviews 150
I would recommend this firm to others. They were always quick to reply to any of my concerns, especially Shelly. She would answer my emails almost immediately. Highly professional and hassle free.
Kelly Wheeler
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038